Form 4: U.S. Physical Therapy CFO Sells Shares and Discloses Restricted Stock Vesting Schedule

Carey P. Hendrickson, CFO of U.S. Physical Therapy Inc., sold 516 shares of common stock at $96.25 per share and disclosed a vesting schedule for restricted stock grants.

Summary

• Carey P. Hendrickson, the Chief Financial Officer of U.S. Physical Therapy Inc., sold 516 shares of the company's common stock on December 9, 2024, at a price of $96.25 per share.
• Following the transaction, Mr. Hendrickson directly owns 20,469 shares of U.S. Physical Therapy stock.
• The filing also details the vesting schedule for 11,046 shares of restricted stock granted to Mr. Hendrickson under the company's 2003 Stock Incentive Plan.
• The restricted stock vests in tranches over several years, starting with 1,209 shares on January 1, 2025, and continuing through January 1, 2028, with varying amounts vesting each quarter, contingent on his continued service as a director.

Sentiment

Score: 5

Explanation: The document is neutral, detailing a routine stock sale and vesting schedule. There is no indication of positive or negative sentiment.

Risks

• The sale of shares by a high-ranking executive could be interpreted negatively by the market, although the amount is relatively small.
• The vesting of restricted stock is contingent on Mr. Hendrickson remaining a director, which introduces a risk of forfeiture if he leaves the company.

Industry Context

This is a routine filing related to insider trading and stock-based compensation, which is common in publicly traded companies. The sale of shares by an executive is a normal occurrence and does not necessarily indicate a negative outlook for the company.

Comparison to Industry Standards

• Executive stock sales and restricted stock grants are standard practices across publicly traded companies, including those in the healthcare sector like Select Medical Holdings Corporation (SEM) and Encompass Health Corporation (EHC).
• The vesting schedules for restricted stock are also typical, often tied to continued employment or performance milestones.
• The number of shares sold by the CFO is relatively small compared to the total shares outstanding, and the price is consistent with recent trading activity.

Stakeholder Impact

• The sale of shares by the CFO could have a minor negative impact on shareholder sentiment, although the amount is small.
• The vesting of restricted stock provides an incentive for the CFO to remain with the company, which is beneficial for stakeholders.

Key Dates

Keywords

insider trading, stock sale, restricted stock, vesting schedule, CFO, USPH, U.S. Physical Therapy